Ipafricept

N/A

Report date: 2022/10/24 13:06:54

Base Information

Drug NameIpafricept
Drug Alias NameIpafricept (Fzd8-Fc融合蛋白)OMP-54F28FZD8-Fc
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionWnt signalling pathway inhibitorsFrizzled-8 modulators
TargetsFrizzled-8
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncomed Pharmaceuticals IncBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncomed Pharmaceuticals IncBayer AG
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A